Key result
This article outlines principles for differentiating and selecting among drugs of the same class in cardiology.
Key points are not available for this paper at this time.
Design
Review
May inform intra-class drug selection where evidence ends; leaves open head-to-head trials to validate principles.
uch of medicine is concerned with choosing the right treatment, and cardiologists have done well in recent years to ensure the choice is supported by good evidence. However, the greatest choice often starts where the evidence finishes-namely between drugs of the same class. This article seeks therefore to offer the principles which govern when and how it is appropriate to differentiate drugs within a class, and discuss topical examples among the drugs commonly used in cardiology.
No takes yet. Share an insight, caveat, or question.
M. J Brown (2003) reported a review. This article outlines principles for differentiating and selecting among drugs of the same class in cardiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: